Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences (BUMS), Birjand, Iran; Faculty of Pharmacy, Birjand University of Medical Sciences, Birjand, Iran.
Biomed Pharmacother. 2021 Apr;136:111214. doi: 10.1016/j.biopha.2020.111214. Epub 2021 Jan 12.
Cardiovascular diseases (CVDs) are one of the leading causes of the most considerable mortality globally, and it has been tried to find the molecular mechanisms and design new drugs that triggered the molecular target. Curcumin is the main ingredient of Curcuma longa (turmeric) that has been used in traditional medicine for treating several diseases for years. Numerous investigations have indicated the beneficial effect of Curcumin in modulating multiple signaling pathways involved in oxidative stress, inflammation, apoptosis, and proliferation. The cardiovascular protective effects of Curcumin against CVDs have been indicated in several studies. In the current review study, we provided novel information on Curcumin's protective effects against various CVDs and potential molecular signaling targets of Curcumin. Nonetheless, more studies should be performed to discover the exact molecular target of Curcumin against CVDs.
心血管疾病(CVDs)是全球导致死亡率最高的主要原因之一,人们一直在试图寻找分子机制并设计新的药物来触发分子靶点。姜黄素是姜黄( turmeric)的主要成分,多年来一直被用于传统医学治疗多种疾病。大量研究表明,姜黄素在调节涉及氧化应激、炎症、细胞凋亡和增殖的多种信号通路方面具有有益作用。姜黄素对 CVDs 的心血管保护作用已在多项研究中得到证实。在本综述研究中,我们提供了关于姜黄素对各种 CVDs 的保护作用及其潜在分子信号靶点的新信息。然而,仍需要开展更多的研究来发现姜黄素针对 CVDs 的确切分子靶点。